NCT07864805Completed
Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes
Efficacy of Electromagnetic Field Therapy on Improving Quality of Life and Gait Performance in Patients With Type 2 Diabetes Mellitus and Peripheral Arterial Disease. Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial was to investigate the efficacy of Low frequency pulsed electromagnetic therapy (LFPEMT) in improving vascular-related quality of life (VQ) and spatiotemporal gait parameters in individuals with Type 2 Diabetes mellitus (T2DM) and Peripheral arterial disease (PAD). The main questions it aimed to answer are: * Is the LFPEMT effective in improving VQ in patients with T2DM and PAD? * Is the LFPEMT effective in improving spatiotemporal gait parameters in patients with T2DM and PAD? Researchers compared group A (received LFPEMT plus interval exercise training program) to group B (received placebo LFPEMT plus the same interval exercise training program) to see if LFPEMT is effective in improving gait parameters and vascular related quality of life in patients with T2DM and PAD. Participants in group A received LFPEMT plus moderate intensity interval training, while participants in group B received placebo LFPEMT plus the same moderate intensity interval training.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 2 Oct 2026
- Start date
- 1 Jul 2025
- Primary completion date
- 9 Apr 2026
- Lead sponsor
- Ashraf Abdelaal
- Diseases
- Type 2 diabetes
- NCT number
- NCT07864805
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Jul 2025 to the primary completion date, 9 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Insulin therapy.
Other illness
- Recent infectious or serious cardiopulmonary or neuromusculoskeletal conditions that could compromise participant safety or affect the accuracy of study outcomes.
Age
- 60\<age\<70 years.
Other
- Implanted electronic devices.
- Uncontrolled blood pressure.
- Participation in any structured dietary or exercise programs within the last 6 months.
- Refusal to provide written informed consent for participation in the study and publication of its results.
Who the study is looking for
- Individuals aged 60-70 years
- Medically controlled T2DM for more than 5 years, treated with oral antidiabetic medications only.
- Glycated haemoglobin (HbA1c) levels \>6.5% and ≤11%.
- Established diagnosis of PAD Stage I and IIa or Rutherford stage 0 and 1.
- Mild peripheral arterial obstruction (0.7\< ABI\<0.9).
- Medically controlled blood pressure and sedentary life style.
- Body mass index (BMI)\<30 kg/m2; and and adequate cognitive function.
Age in the registry: 60 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Umm Al-Qura University Coordinator of this site? Confirm its status | Mecca | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.